EUVIMEDEUVIMED entdecken
Crossref

An SMN2 splicing-correcting antisense oligonucleotide promotes gene looping and transcription activation

Jose N Stigliano, Emilia Haberfeld, Luciano E Marasco, Ana Fiszbein, Nick J Proudfoot, Alberto R Kornblihtt

Molecular Cell · 2026-11

DOI: 10.1016/j.molcel.2026.10.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Cell, 2026-11. Verfasst von Jose N Stigliano und 5 weiteren Autor:innen. Beteiligte Einrichtung: Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales, Departamento de Fisiología, Biología Molecular y Celular, 1428 Buenos Aires, A…. Die Arbeit nennt 52 Literaturangaben. Gefördert von: Fund for Scientific and Technological Research, Secretaria de Ciencia y Tecnica, Universidad de Buenos Aires, University of Oxford Linacre College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We have previously proposed a combined therapy for spinal muscular atrophy based on the upregulation of exon 7 (E7) inclusion into SMN2 mRNA by the antisense oligonucleotide nusinersen (ASO1) together with histone deacetylase inhibitors (HDACi). Using a CRISPR-deadCas-based strategy in a human cell line, we show here that targeting histone acetylation at the SMN2 E7 region duplicates the HDACi effect, which overcomes pleiotropic effects. Most noticeably, targeted acetylation at the E7 region causes acetylation and activation of the 30-kbp-distant promoter. Since the nusinersen target site maps near the SMN2 gene 3' end, this crosstalk between the two ends of the gene prompted us to use chromosome conformation analysis (3C) to find that ASO1 promotes gene looping. This unpredicted property of ASOs in modulating chromatin 3D configuration depends on cohesin, CTCF, cleavage/polyadenylation factors, and a canonical poly(A) signal and causes promoter activation at a long distance, which expands the therapeutic potential of splicing-correcting ASOs.

Schlagwörter

Stichwörter der Autor:innen

alternative splicingantisense oligonucleotide therapychromatin 3D structurecleavage/polyadenylation factorsgene loopingspinal muscular atrophytranscriptional activation

Autor:innen und Institutionen

  • Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales, Departamento de Fisiología, Biología Molecular y Celular, 1428 Buenos Aires, Argentina; CONICET-Universidad de Buenos Aires, Instituto de Fisiología…
  • Sir William Dunn School of Pathology, University of Oxford, Oxford OX13RE, UK.
  • Biology Department, Boston University, Boston, MA 02215, USA.

Förderung

  • Fund for Scientific and Technological Research
  • Secretaria de Ciencia y Tecnica, Universidad de Buenos Aires
  • University of Oxford Linacre College
  • Richard Lounsbery Foundation Inc

Zitieren

APA

Stigliano, J. N., Haberfeld, E., Marasco, L. E., Fiszbein, A., Proudfoot, N. J., & Kornblihtt, A. R. (2026). An SMN2 splicing-correcting antisense oligonucleotide promotes gene looping and transcription activation. Molecular Cell. https://doi.org/10.1016/j.molcel.2026.10.009

Vancouver

Stigliano JN, Haberfeld E, Marasco LE, Fiszbein A, Proudfoot NJ, Kornblihtt AR. An SMN2 splicing-correcting antisense oligonucleotide promotes gene looping and transcription activation. Molecular Cell. 2026. doi:10.1016/j.molcel.2026.10.009

BibTeX
@article{Stigliano2026,
  author = {Stigliano, Jose N and Haberfeld, Emilia and Marasco, Luciano E and Fiszbein, Ana and Proudfoot, Nick J and Kornblihtt, Alberto R},
  title = {An SMN2 splicing-correcting antisense oligonucleotide promotes gene looping and transcription activation},
  journal = {Molecular Cell},
  year = {2026},
  doi = {10.1016/j.molcel.2026.10.009}
}
Kostenlos starten →